This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canine Symmetric dimethylarginine (SDMA) ELISA Kit-Competitive
Product Overview
BioVenic Canine Symmetric dimethylarginine (SDMA) ELISA Kit-Competitive is designed for the quantitative determination of Canine Symmetric dimethylarginine (SDMA) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Competitive ELISA method. For research use only.
Specifications
Target Information
Symmetric dimethylarginine (SDMA) is a sensitive renal biomarker whose concentration increases earlier than creatinine as glomerular filtration rate decreases. It serves as an alternative marker for glomerular filtration rate (GFR), which reflects kidney function. SDMA offers a promising avenue for assessing renal health, providing a valuable tool for clinicians. It is considered an important biomarker of renal dysfunction in humans and small animals. SDMA may also be a useful tool in canine acute pancreatitis.
Shipping and Storage
This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
References
- Gori, E. et al. Evaluation of Symmetric Dimethylarginine (SDMA) in Dogs with Acute Pancreatitis. Veterinary sciences. 2020, 7.